Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/1998
11/10/1998US5834455 Photosensitizers for sensitizing cells
11/10/1998US5834425 Composite of lectin and epidermal growth factor domains, treatment of pathological leukocyte mediated inflammation
11/10/1998US5834293 Nucleic acid which codes for epoxygenase enzyme
11/10/1998US5834025 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
11/10/1998US5834020 Diagnostic imaging
11/10/1998US5833948 Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
11/10/1998US5833947 Monitoring the vasodilatory or vasoconstrictive effects of a physiologically active substance
11/10/1998US5833946 Treating immunosuppressed mammals with medicant prior to administering candida species via the airways, compare with control group; identifying medications for treating candidiasis undetected by classical methods
11/10/1998US5833613 Ultrasonic diagnostic imaging with contrast agents
11/10/1998US5832931 Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
11/05/1998WO1998049336A1 Metastasis models using green fluorescent protein (gfp) as a marker
11/05/1998WO1998049314A2 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI)
11/05/1998WO1998049269A1 Genetically engineered animals containing null mutations in the neurofilament genes
11/05/1998WO1998049196A1 Calcitonin receptor-binding peptides
11/05/1998WO1998048847A1 Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization
11/05/1998WO1998048846A1 Light imaging contrast agents
11/05/1998WO1998048845A1 Method of demarcating tissue
11/05/1998WO1998048844A2 Ion paris, method for the production and use thereof as contrast agents
11/05/1998WO1998048838A1 Compounds
11/05/1998WO1998048783A1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
11/05/1998WO1998032469A3 Polymers
11/05/1998CA2289019A1 Calcitonin receptor-binding peptides
11/05/1998CA2288211A1 Antigenic composition and method of detection for helicobacter pylori
11/04/1998EP0874645A2 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics
11/04/1998EP0874644A2 Gas bubble suspensions and their application as an ultrasound contrast medium
11/04/1998EP0656950B1 Tat-derived transport polypeptides
11/04/1998EP0486622B1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
11/03/1998US5831088 Osmylation
11/03/1998US5830670 Definitive diagnostic test
11/03/1998US5830435 Method of storing frozen microbubble suspensions
11/03/1998US5830434 Methods of treating non-insulin dependent diabetes mellitus with pancreatic polypeptide
10/1998
10/29/1998WO1998047969A1 Alkyl, alkenyl and alkynyl chrysamine g derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
10/29/1998WO1998047856A1 Contrast agent preparation
10/29/1998WO1998047541A1 Contrast agents
10/29/1998WO1998047540A1 Contrast agents comprising an azeotropic mixture of two gases for ultrasound investigations
10/29/1998WO1998047539A1 Nmr image compounds
10/29/1998WO1998047538A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
10/29/1998WO1998047533A1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent
10/29/1998WO1998047532A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents
10/29/1998DE19717904A1 Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie Acid labile and enzymatically cleavable dye constructs for diagnosis and therapy with near-infrared light
10/29/1998CA2288292A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents
10/29/1998CA2287245A1 Contrast agent preparation
10/29/1998CA2286607A1 Alkyl, alkenyl and alkynyl chrysamine g derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
10/28/1998EP0873408A1 Calcium binding proteolipid compositions and methods
10/28/1998EP0873139A1 Antibodies with reduced net positive charge
10/28/1998EP0873091A1 Apparatus and method for marking tissue
10/28/1998EP0759742B1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
10/28/1998EP0660687B1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
10/28/1998EP0652746B1 Lymphatic delivery composition
10/27/1998US5827655 Product of the mk3 gene; identifying immune response
10/27/1998US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits
10/27/1998US5827504 Suspension of gas microbubbles bounded by evanescent envelope or membrane immobilized within frozen carrier liquid; echo imaging contrast agent
10/27/1998US5827502 Microparticulate microbubble-generating contrast agents
10/27/1998US5827501 Use of free radicals in ESR and ESREMR imaging
10/27/1998US5827500 Process for identifying RAR-receptor-antagonist compounds
10/22/1998WO1998046634A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
10/22/1998WO1998046276A1 Chelating agents
10/22/1998WO1998046275A2 Blood-pool carrier for lipophilic imaging agents
10/22/1998WO1998031399A3 Labelled factor xiiia substrates
10/22/1998CA2286790A1 Chelating agents
10/22/1998CA2286138A1 Blood-pool carrier for lipophilic imaging agents
10/21/1998EP0872479A1 Chelated complexes of paramagnetic metals with low toxicity
10/21/1998EP0871896A1 A method of determining oxygen concentration in a sample
10/21/1998EP0871709A1 Androgen-repressed metastatic human prostate cancer cell line
10/21/1998EP0871637A1 Tungsten clusters
10/21/1998EP0871608A1 Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
10/21/1998EP0871499A1 Nucleation and activation techniques for use in ultrasound imaging
10/21/1998EP0871498A1 Insoluble gas-filled microspheres containing a hydrophobic barrier
10/21/1998EP0871497A1 High-resolution method of imaging part of a biological object using electromagnetic radiation together with a contrast medium
10/21/1998EP0871492A2 Mesothelium antigen and methods and kits for targeting it
10/21/1998EP0871431A2 Hepatocyte-selective oil-in-water emulsion
10/21/1998EP0731786B1 Biphenyl iodinated derivatives and their diagnostic use
10/21/1998CN1040328C Preparation method of complex salts of hematoporphyrin and of its derivatives
10/20/1998US5824821 Epoxidation of allylamino compound, hydrolysis to yield 2,3-dihydroxypropylamino compounds
10/20/1998US5824781 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/20/1998US5824288 Contrast agents for magnetic resonance imaging
10/20/1998US5824286 Administering gonadotropin releasing hormone antagonist before mammogram
10/15/1998WO1998044910A1 NEW TECHNIQUE TO MONITOR DRUG DELIVERY NONINVASIVELY $i(IN VIVO)
10/15/1998WO1998022146A3 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation)
10/15/1998CA2281843A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
10/14/1998EP0870770A1 A trans-platinum based compound, a diagnostic kit comprising said compound and a method for labeling a bio-organic molecule wherein use is made of said compound
10/14/1998CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/13/1998US5821354 Synthesizing a dna sequence in at least two parts; labeling the 5' end of one with a radioisotope; hybridizing; ligating; useful to prevent uncontrolled cellular proliferation
10/13/1998US5821072 Combinations of PKC inhibitors and therapaeutic agents for treating cancers
10/13/1998US5821065 Immunoassay for the detection of collagen I
10/13/1998US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998US5820851 Tripodal pyridine ligands as MRI contrast agents
10/13/1998US5820850 Suspension of microspheres comprising outer membrane of amphiphilic amino acid block copolymer having hydrophobic and hydrophilic blocks encapsulating water insoluble pharmacologically acceptable gas
10/13/1998US5820849 Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes
10/13/1998US5820848 Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
10/13/1998US5820847 Administering a diagnostic agent complexed with a targeting ligand of folates or receptor-binding derivatives; for transporting exogenous molecules into cells with folate receptors; drug delivery
10/08/1998WO1998044095A1 Transgenic animal with controllable hyperproliferation and inflammation phenotype in the skin
10/08/1998WO1998043630A1 Means of ascertaining an individual's risk profile for atherosclerotic disease
10/08/1998CA2285091A1 Means of ascertaining an individual's risk profile for atherosclerotic disease
10/07/1998EP0868921A2 Medical gas mixtures
10/07/1998EP0868434A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/07/1998EP0868202A1 Cascade polymer complexes, process for producing the same and pharmaceuticals containing the same
10/07/1998EP0868201A1 Detecting prions in a sample and prion preparation and transgenic animal used for same
10/07/1998EP0868200A1 Suspended ultra-sound induced microbubble cavitation imaging
10/07/1998EP0855997A4 Formyl derivatives as nonionic contrast media
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 354